TSHA Smart Money
Taysha Gene Therapies, Inc.
1W: -0.9%
1M: -17.9%
3M: -27.4%
YTD: -11.8%
1Y: +45.6%
3Y: +55.9%
5Y: -76.9%
$4.63
-0.11 (-2.32%)
Weekly Expected Move ±5.9%
$4
$4
$5
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026234
Institutions Holding
+9 vs prior
139.8%
Ownership
+59.13%
46
New
97
Increased
63
Reduced
22
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-10 | Nagendran Sukumar | officer: president and head of r&d | S-Sale | 200,000 | $6.24 | $1.2M | Filing |
| 2026-06-01 | Long Alison S | director | A-Grant/Award | 21,335 | $— | $0 | Filing |
| 2026-06-01 | Sepp-Lorenzino Laura | director | A-Grant/Award | 21,335 | $— | $0 | Filing |
| 2026-06-01 | Stalfort John A III | director | A-Grant/Award | 21,335 | $— | $0 | Filing |
| 2026-06-01 | Donenberg Phillip B. | director | A-Grant/Award | 21,335 | $— | $0 | Filing |
| 2026-02-04 | Alam Kamran | officer: chief financial officer | S-Sale | 1,655 | $4.52 | $7K | Filing |
| 2026-01-26 | Alam Kamran | officer: chief financial officer | S-Sale | 23,849 | $4.61 | $110K | Filing |
| 2026-01-26 | Nagendran Sukumar | officer: president and head of r&d | S-Sale | 26,918 | $4.61 | $124K | Filing |
| 2026-01-26 | Nolan Sean P. | officer: chief executive officer | S-Sale | 41,312 | $4.61 | $190K | Filing |
| 2026-01-23 | Alam Kamran | officer: chief financial officer | S-Sale | 78,968 | $4.75 | $375K | Filing |
| 2026-01-23 | Nagendran Sukumar | officer: president and head of r&d | S-Sale | 89,132 | $4.75 | $423K | Filing |
| 2026-01-23 | Nolan Sean P. | officer: chief executive officer | S-Sale | 136,789 | $4.75 | $650K | Filing |
| 2026-01-12 | Alam Kamran | officer: chief financial officer | A-Grant/Award | 359,000 | $— | $0 | Filing |
| 2026-01-12 | Nagendran Sukumar | officer: president and head of r&d | S-Sale | 200,000 | $4.71 | $942K | Filing |
| 2026-01-12 | Nagendran Sukumar | officer: president and head of r&d | A-Grant/Award | 427,000 | $— | $0 | Filing |
| 2026-01-12 | Nolan Sean P. | officer: chief executive officer | A-Grant/Award | 1,008,000 | $— | $0 | Filing |
| 2025-12-01 | Nagendran Sukumar | officer: president and head of r&d | S-Sale | 260,047 | $4.51 | $1.2M | Filing |
| 2025-11-28 | Nagendran Sukumar | officer: president and head of r&d | S-Sale | 110,125 | $4.75 | $523K | Filing |
| 2025-09-10 | Nagendran Sukumar | officer: president and head of r&d | S-Sale | 200,000 | $3.23 | $646K | Filing |
| 2025-08-21 | Nagendran Sukumar | officer: president and head of r&d | S-Sale | 57,054 | $2.85 | $163K | Filing |
| 2025-08-21 | Alam Kamran | officer: chief financial officer | S-Sale | 54,491 | $2.85 | $155K | Filing |
| 2025-06-02 | Sepp-Lorenzino Laura | director | A-Grant/Award | 56,623 | $— | $0 | Filing |
| 2025-06-02 | Stalfort John A III | director | A-Grant/Award | 56,623 | $— | $0 | Filing |
| 2025-06-02 | Long Alison S | director | A-Grant/Award | 56,623 | $— | $0 | Filing |
| 2025-06-02 | Donenberg Phillip B. | director | A-Grant/Award | 56,623 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 23,888,888 | $163M | +2,188,888 | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 23,555,648 | $160M | — | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 22,713,118 | $155M | +343,473 | 2026-06-30 | Filing |
| BlackRock, Inc. | 20,691,927 | $141M | +2,326,319 | 2026-06-30 | Filing |
| Vestal Point Capital, LP | 19,415,000 | $132M | +1,415,000 | 2026-06-30 | Filing |
| MORGAN STANLEY | 16,487,479 | $112M | -1,477,892 | 2026-06-30 | Filing |
| RTW INVESTMENTS, LP | 13,560,258 | $92M | -119,990 | 2026-06-30 | Filing |
| FMR LLC | 13,336,413 | $91M | -984,842 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 12,478,595 | $85M | +2,247,093 | 2026-06-30 | Filing |
| STATE STREET CORP | 11,421,920 | $78M | +212,842 | 2026-06-30 | Filing |
| Siren, L.L.C. | 9,846,579 | $67M | +1,016,666 | 2026-06-30 | Filing |
| Octagon Capital Advisors LP | 9,693,244 | $66M | +833,333 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 6,560,394 | $45M | +1,028,439 | 2026-06-30 | Filing |
| Polar Capital Holdings Plc | 5,117,133 | $35M | -537,207 | 2026-06-30 | Filing |
| MPM BIOIMPACT LLC | 4,500,000 | $31M | +4,500,000 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 4,398,652 | $30M | -28,649 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 4,004,756 | $27M | — | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 3,975,605 | $27M | +3,349,244 | 2026-06-30 | Filing |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST | 3,885,501 | $26M | +1,002,200 | 2026-06-30 | Filing |
| GordonMD Global Investments LP | 723,185 | $25M | -14,365 | 2026-06-30 | Filing |